...
首页> 外文期刊>American Journal of Physiology >MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.
【24h】

MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.

机译:MicroRNA-29c在尿液外/微胶中作为肾纤维化的生物标志物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Micro (mi)RNAs are frequently dysregulated in the development of renal fibrosis. Exosomes are small membrane vesicles that could be isolated from urine secreted from all nephron segments. Here we sought to observe for the first time whether miRNA in urine exosome could serve as a potential biomarker of renal fibrosis. Urine samples were collected from 32 chronic kidney disease (CKD) patients who underwent kidney biopsy and 7 controls. Exosome was isolated and confirmed by immunogold staining of exosome marker. Members of miR-29, miR-200, and RNU6B as endogenous control were detected by RT quantitative PCR. Electronic microscopy verified a typical shape of exosome with average size of 65.1 nm and labeled it with anti-CD9 and anti-aquaporin 2 antibody. Members of miR-29 and miR-200 are readily measured with reduced levels compared with controls (P < 0.05) and can robustly distinguish CKD from controls [area under the curve (AUC) varied from 0.902 to 1 by receiver operating characteristics analysis]. miR-29c correlated with both estimated glomerular filtration rate (r — 0.362; P < 0.05) and degree of tubulointerstitial fibrosis (r = -0.359; P < 0.05) for CKD patients. Moreover, miRNA in exosome was decreased in mild fibrosis group compared with moderated to severe group. miR-29a and miR-29c could predict degree of tubulointerstitial fibrosis with AUC of 0.883 and 0.738 (P < 0.05). The sensitivity and specificity for distinguishing mild from moderate to severe fibrosis were 93.8 and 81.3% with the use of miR-29a and 68.8 and 81.3% for miR-29c. Overall, miR-29c in urinary exosome correlates with both renal function and degree of histological fibrosis, suggesting it as a novel, noninvasive marker for renal fibrosis.
机译:Micro(MI)RNA经常在肾纤维化的发展中进行过度测定。外泌体是小膜囊泡,可从所有肾周围分泌的尿液中分离。在这里,我们首次试图观察尿液中的miRNA是否可以作为肾纤维化的潜在生物标志物。从32例慢性肾病(CKD)患者接受肾活检和7种对照的患者中收集了尿液样本。通过外泌体标记物的免疫染色染色分离和证实外来体。通过RT定量PCR检测MiR-29,MiR-200和RNU6B的成员作为内源性对照。电子显微镜验证了外出的典型形状,平均尺寸为65.1nm,并用抗CD9和抗Aquaporin 2抗体标记。与对照组相比,MiR-29和MiR-200的成员随着水平降低的水平而变化(P <0.05),并且通过接收器操作特性分析,可以鲁棒地区分CKD [曲线下的区域(AUC)的区域(AUC)的控制。 MIR-29C与估计的肾小球过滤速率(R - 0.362; P <0.05)和微管间纤维化程度(R = -0.359; P <0.05)相关。此外,与严重组相比,轻度纤维化组中外肌肉组中的miRNA降低。 miR-29a和miR-29c可以预测菌微管癖纤维化程度为0.883和0.738(p <0.05)。将温和温和的敏感性和特异性与中度至重度纤维化区别为93.8和81.3%,使用miR-29a和68.8和miR-29c的81.3%。总体而言,MiR-29C在尿液中与肾功能和组织学纤维化的程度相关,表明它是一种新的肾纤维化的非侵入性标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号